223 related articles for article (PubMed ID: 25670065)
1. CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.
Zia H; Murray GI; Vyhlidal CA; Leeder JS; Anwar AE; Bui MM; Ahmed AA
Int J Exp Pathol; 2015 Apr; 96(2):81-6. PubMed ID: 25670065
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
Fellinger EJ; Garin-Chesa P; Glasser DB; Huvos AG; Rettig WJ
Am J Surg Pathol; 1992 Aug; 16(8):746-55. PubMed ID: 1497115
[TBL] [Abstract][Full Text] [Related]
3. Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma?
Pradhan A; Grimer RJ; Spooner D; Peake D; Carter SR; Tillman RM; Abudu A; Jeys L
J Bone Joint Surg Br; 2011 Apr; 93(4):531-6. PubMed ID: 21464495
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW
J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
8. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis.
Fagone P; Nicoletti F; Salvatorelli L; Musumeci G; Magro G
Acta Histochem; 2015 Oct; 117(8):824-8. PubMed ID: 26363896
[TBL] [Abstract][Full Text] [Related]
10. Expression of neural cell adhesion molecules and neurofilament protein isoforms in Ewing's sarcoma of bone and soft tissue sarcomas other than rhabdomyosarcoma.
Molenaar WM; Muntinghe FL
Hum Pathol; 1999 Oct; 30(10):1207-12. PubMed ID: 10534169
[TBL] [Abstract][Full Text] [Related]
11. Non-Metastatic Pelvic Ewing's Sarcoma : oncologic outcomes and evaluation of prognostic factors.
Dramis A; Grimer RJ; Malizos K; Tillman RM; Jeys L; Carter LR
Acta Orthop Belg; 2016 Aug; 82(2):216-221. PubMed ID: 27682283
[TBL] [Abstract][Full Text] [Related]
12. Multimodality treatment of intradural extramedullary Ewing's sarcomas. A systematic review.
Paterakis KN; Brotis A; Dardiotis E; Giannis T; Tzerefos C; Fountas KN
Clin Neurol Neurosurg; 2018 Jan; 164():169-181. PubMed ID: 29247908
[TBL] [Abstract][Full Text] [Related]
13. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
[TBL] [Abstract][Full Text] [Related]
14. Hernias and Ewing's sarcoma family of tumours: a pooled analysis and meta-analysis.
Valery PC; Holly EA; Sleigh AC; Williams G; Kreiger N; Bain C
Lancet Oncol; 2005 Jul; 6(7):485-90. PubMed ID: 15992697
[TBL] [Abstract][Full Text] [Related]
15. Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma. A report from the Kiel Pediatric Tumor Registry.
Schmidt D; Herrmann C; Jürgens H; Harms D
Cancer; 1991 Nov; 68(10):2251-9. PubMed ID: 1655208
[TBL] [Abstract][Full Text] [Related]
16. Glycogen-containing neuroblastoma with clinical and histopathologic features of Ewing's sarcoma.
Triche TJ; Ross WE
Cancer; 1978 Apr; 41(4):1425-32. PubMed ID: 639002
[TBL] [Abstract][Full Text] [Related]
17. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.
Evans RG; Nesbit ME; Gehan EA; Garnsey LA; Burgert O; Vietti TJ; Cangir A; Tefft M; Thomas P; Askin FB
J Clin Oncol; 1991 Jul; 9(7):1173-80. PubMed ID: 2045857
[TBL] [Abstract][Full Text] [Related]
18. Ewing's tumour. A study of behaviour and treatment in forty-seven cases.
Macintosh DJ; Price CH; Jeffree GM
J Bone Joint Surg Br; 1975 Aug; 57(3):331-40. PubMed ID: 1057545
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
Abudu A; Mangham DC; Reynolds GM; Pynsent PB; Tillman RM; Carter SR; Grimer RJ
Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal rearrangement t(11;22) in extraskeletal Ewing's sarcoma and primitive neuroectodermal tumour analysed by fluorescence in situ hybridization using paraffin-embedded tissue.
Nagao K; Ito H; Yoshida H; Minamizaki T; Furuse K; Yoshikawa T; Ushigome S
J Pathol; 1997 Jan; 181(1):62-6. PubMed ID: 9072004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
